Abstract
Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare type of lung squamous cell carcinoma. In situ hybridization test for Epstein-Bar virus-encoded RNA (EBER) is generally used for distinguishing it from other lung cancers. Although plasma EBV DNA quantification has been widely used as a tumor biomarker in nasopharyngeal carcinoma (NPC), only a limiting number of studies have suggested that plasma EBV DNA quantification may be used as a tumor marker in pulmonary LELC patients. We report two female patients diagnosed as poorly differentiated squamous cell carcinoma, subsequently, their further histological examinations showed that tumor cells were EBER positive and plasma EBV DNA was detectable. Two patients was diagnosed with advanced pulmonary LELC. The patients were treated with chemotherapy and chemoradiotherapy respectively. Both patients responded well to our treatment, in accordance with their decreased EBV DNA level. Pulmonary LELC is a rare type of lung cancer which is sensitive to chemoradiotherapy, especially in late staged patients.
References
Sep 10, 1998·Cancer·A T ChanP J Johnson
Jun 8, 2001·American Journal of Clinical Pathology·A J HanM Xiong
Feb 21, 2003·European Radiology·G C OoiK W T Tsang
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Issan Yee San TamMaria P Wong
Apr 25, 2006·AJR. American Journal of Roentgenology·Joseph M HoxworthMichael B Gotway
Jan 27, 2009·Cancer·Daisy Wing-Sze WongUNKNOWN University of Hong Kong Lung Cancer Study Group
Mar 3, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jose Javier Gómez-RománJose Fernando Val-Bernal
Nov 13, 2010·Cancer Science·Yih-Leong ChangYung-Chie Lee
Feb 24, 2012·Cancer·Ying LiangTiehua Rong
Jul 7, 2012·PloS One·She-Juan AnYi-Long Wu
Mar 8, 2013·European Journal of Radiology·Huali MaYing Liang
Mar 19, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S F LeungA T C Chan
Dec 3, 2014·Experimental and Therapeutic Medicine·Rui LiangWan-Pu Wang
Apr 9, 2015·PloS One·Ting ShenHai-Qiang Mai
Sep 12, 2015·Oncotarget·Wenfeng FangLi Zhang
Jan 1, 2014·Thoracic Cancer·Qianwen LiuJianhua Fu
Mar 20, 2016·Interactive Cardiovascular and Thoracic Surgery·Zhichao LinJianxing He